# Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer

> **NCT01608464** · PHASE2 · TERMINATED · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 170 (actual)

## Conditions studied

- Carcinoma of Esophagus

## Interventions

- **DRUG:** irinotecan and docetaxel
- **DRUG:** Cisplatin, fluorouracil and concurrent radiation therapy

## Key facts

- **NCT ID:** NCT01608464
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 170 (ACTUAL)
- **Why stopped:** poor accrual
- **Last updated:** 2018-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01608464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01608464, "Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01608464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*